Citation Impact
Citing Papers
Development of an mRNA-lipid nanoparticle vaccine against Lyme disease
2023 StandoutNobel
Rodent-borne diseases and their risks for public health
2009 Standout
Recognition of Borrelia burgdorferi , the Lyme Disease Spirochete, by TLR7 and TLR9 Induces a Type I IFN Response by Human Immune Cells
2009
The year that shaped the outcome of the OspA vaccine for human Lyme disease
2022
Plasmid DNA and protein vaccination of mice to the outer surface protein A of Borrelia burgdorferi leads to induction of T helper cells with specificity for a major epitope and augmentation of protective IgG antibodies in vivo
1996
Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults
1996
Safety and Immunogenicity of an Outer Surface Protein A Vaccine in Subjects with Previous Lyme Disease
1995
Design and Development of a Novel Vaccine for Protection against Lyme Borreliosis
2014
Antiinflammatory and Immunosuppressive Activity of Sialostatin L, a Salivary Cystatin from the Tick Ixodes scapularis
2006
The atomic structure of protein-protein recognition sites 1 1Edited by A. R. Fersht
1999 Standout
DNA Fragment Length Polymorphism Analysis of Mycobacterium tuberculosis Isolates by Arbitrarily Primed Polymerase Chain Reaction
1993
Perspective on the development of vaccines against Lyme disease
1991
Development of Lyme Arthritis in Mice Deficient in Inducible Nitric Oxide Synthase
1999
A Vaccine Consisting of RecombinantBorrelia burgdorferiOuter-Surface Protein A to Prevent Lyme Disease
1998
Macrophages: Master Regulators of Inflammation and Fibrosis
2010 Standout
Natural Lyme disease cycles maintained via sheep by co-feeding ticks
1997
Immunodominant proteins of Borrelia burgdorferi, the etiological agent of lyme borreliosis
1991
Western Blotting in the Serodiagnosis of Lyme Disease
1993 Standout
Toll-like receptors in innate immunity
2004 Standout
Outer surface protein a (OspA) from the lyme disease spirochete, borrelia burgdorferi: High level expression and purification of a soluble recombinant form of OspA
1990
Hepatitis B Virus Capsid-like Particles Can Display the Complete, Dimeric Outer Surface Protein C and Stimulate Production of Protective Antibody Responses against Borrelia burgdorferi Infection
2006
Intracellular Toll-like Receptors
2010 StandoutNobel
Vaccination against Lyme Disease with RecombinantBorrelia burgdorferiOuter-Surface Lipoprotein A with Adjuvant
1998 Standout
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
2015 Standout
Incongruent effects of two isolates of Rickettsia conorii on the survival of Rhipicephalus sanguineus ticks
2009
Fatty Acids Modulate Toll-like Receptor 4 Activation through Regulation of Receptor Dimerization and Recruitment into Lipid Rafts in a Reactive Oxygen Species-dependent Manner
2009 Standout
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 Standout
Cefotaxime versus penicillin in the late stage of lyme disease — prospective, randomized therapeutic study
1990
Tick immunity using mRNA, DNA and protein-based Salp14 delivery strategies
2021 StandoutNobel
Floor plate and motor neuron induction by vhh-1, a vertebrate homolog of hedgehog expressed by the notochord
1994 Standout
Lipid Exchange between Borrelia burgdorferi and Host Cells
2013
A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula
2005
Pyroptosis: mechanisms and diseases
2021 Standout
Ticks and Tickborne Bacterial Diseases in Humans: An Emerging Infectious Threat
2001 Standout
The outer surface protein A (OspA) ofBorrelia burgdorferi: A vaccine candidate and bioactive mediator
1996
Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family
2001
Oxidation of NG‐hydroxyl‐l ‐arginine to nitric oxide mediated by respiratory burst: an alternative pathway to NO synthesis
1997
Immune responses induced by spirochetal outer membrane lipoproteins and glycolipids
2008
Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice
2002
Experimental immunization against Lyme borreliosis with recombinant Osp proteins: An overview
1996
Studies on OspA: A source of new paradigms in Lyme disease research
1998
The Essential Role of Tick Salivary Glands and Saliva in Tick Feeding and Pathogen Transmission
2017
Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: New particulate Lyme disease vaccines
2007
Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions
2015 Standout
Elucidation of Lyme arthritis
2004
Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow‐derived macrophages by TH 1 and TH 2 cytokines
1995
Lyme borreliosis
2011 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Induction of experimental allergic arthritis with outer surface proteins of borrelia burgdorferi
1994
Pathogen Recognition and Innate Immunity
2006 Standout
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
2016 Standout
Lyme borreliosis in Europe and North America
2004
Prospective Study of Serologic Tests for Lyme Disease
2008
Macrophage activation and polarization
2007 Standout
The immunobiology of schistosomiasis
2002 Standout
The emergence of Lyme disease
2004
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis.
1994
Toll-Like Receptors
2003 Standout
EFFECTS OF BIODIVERSITY ON ECOSYSTEM FUNCTIONING: A CONSENSUS OF CURRENT KNOWLEDGE
2005 Standout
Protection of Mice Against the Lyme Disease Agent by Immunizing with Recombinant OspA
1990 Science
Evaluation of genetic divergence among Borrelia burgdorferi isolates by use of OspA, fla, HSP60, and HSP70 gene probes
1992
Nitric oxide and the immune response
2001 Standout
M-1/M-2 Macrophages and the Th1/Th2 Paradigm
2000 Standout
Cutting Edge: Inflammatory Signaling by Borrelia burgdorferi Lipoproteins Is Mediated by Toll-Like Receptor 2
1999 Standout
mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent
2021 StandoutNobel
Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks
2001
Biodiversity series: The function of biodiversity in the ecology of vector-borne zoonotic diseases
2000
The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America
2006 Standout
Urokinase-type plasminogen activator enhances invasion of human T cells (Jurkat) into a fibrin matrix
1994
Spiralin, a mycoplasmal membrane lipoprotein, induces T-cell-independent B-cell blastogenesis and secretion of proinflammatory cytokines
1997 StandoutNobel
Testing the immunocompetence handicap hypothesis: a review of the evidence
2004 Standout
Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab
1997
Tick Salivary Gland Extract Inhibits Killing ofBorrelia afzeliiSpirochetes by Mouse Macrophages
2001
Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology
1997 Standout
Long-term protection of mice from Lyme disease by vaccination with OspA
1992
Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues
1994
Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA
1993
Broadly Protective Multivalent OspA Vaccine against Lyme Borreliosis, Developed Based on Surface Shaping of the C-Terminal Fragment
2020
Nucleotide sequence of the ospAB operon of a Borrelia burgdorferi strain expressing OspA but not OspB
1992
Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi
1995
Quantitative Evaluation of Ehrlichial Burden in Horses after Experimental Transmission of Human Granulocytic Ehrlichia Agent by Intravenous Inoculation with Infected Leukocytes and by Infected Ticks
1999
HEAT-SHOCK PROTEINS, MOLECULAR CHAPERONES, AND THE STRESS RESPONSE: Evolutionary and Ecological Physiology
1999 Standout
Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice.
1992
Update on Tick-Borne Rickettsioses around the World: a Geographic Approach
2013 Standout
The Lyme Disease Vaccine: Conception, Development, and Implementation
2000
Phase Variations of the Mycoplasma penetrans Main Surface Lipoprotein Increase Antigenic Diversity
1999 StandoutNobel
Biodiversity series: The function of biodiversity in the ecology of vector-borne zoonotic diseases
2000
Arginine metabolism: nitric oxide and beyond
1998 Standout
TESTOSTERONE DEPRESSES INNATE AND ACQUIRED RESISTANCE TO TICKS IN NATURAL RODENT HOSTS: A FORCE FOR AGGREGATED DISTRIBUTIONS OF PARASITES
2001
Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection
1995
C-Terminal Invariable Domain of VlsE Is Immunodominant but Its Antigenicity Is Scarcely Conserved among Strains of Lyme Disease Spirochetes
2001
Works of U E Schaible being referenced
Mode of Inoculation of the Lyme Disease Agent Borrelia burgdorferi Influences Infection and Immune Responses in Inbred Strains of Mice
1993
Killing of Borrelia burgdorferi by macrophages is dependent on oxygen radicals and nitric oxide and can be enhanced by antibodies to outer surface proteins of the spirochete
1994
Characterization of Borrelia burgdorferi Associated Antigens by Monoclonal Antibodies
1990
Distinct patterns of protective antibodies are generated against Borrelia burgdorferi in mice experimentally inoculated with high and low doses of antigen
1993
A mouse model for Borrelia burgdorferi infection: approach to a vaccine against Lyme disease
1991
Differential immune responses to Borrelia burgdorferi in European wild rodent species influence spirochete transmission to Ixodes ricinus L. (Acari: Ixodidae)
1994
A 14,000 MW lipoprotein and a glycolipid-like structure of Borrelia burgdorferi induce proliferation and immunoglobulin production in mouse B cells at high frequencies.
1994
Demonstration of antigen-specific T cells and histopathological alterations in mice experimentally inoculated with Borrelia burgdorferi
1989
Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice.
1990